Tominersen
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Tominersen, covering 2026-03-02 to 2026-03-02. Get the full timeline:
Most recent: Clinical Trial Update: GENERATION HD2. A Study to Evaluate the Safety, Biomarkers, and Efficacy of Tominersen Compared With Placebo in Participants With Prodromal and Early Manifest Huntington's Disease [Phase 2]